Investment analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research note issued to investors on Wednesday. The firm set a “buy” rating on the stock.
Mannatech Stock Down 0.4 %
Mannatech stock opened at $8.96 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. Mannatech has a one year low of $6.75 and a one year high of $16.49. The company has a 50-day simple moving average of $11.13 and a 200-day simple moving average of $10.05. The firm has a market capitalization of $16.90 million, a P/E ratio of -11.07 and a beta of 1.06.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its earnings results on Wednesday, March 26th. The company reported $1.20 EPS for the quarter. The firm had revenue of $29.01 million during the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Read More
- Five stocks we like better than Mannatech
- What is a support level?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- Ride Out The Recession With These Dividend KingsĀ
- Top 3 Beverage Stocks Pouring Out Profits
- High Dividend REITs: Are They an Ideal Way to Diversify?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.